The levonorgestrel-releasing intrauterine device reduces CA-125 serum levels in patients with endometriosis

被引：23
作者：
Rosa e Silva, Ana Carolina Japur de Sa
Rosa e Silva, Jdlio Cesar
Nogueira, Antnio Alberto
Petta, Carlos Alberto
Abrao, Mauricio Simoes
Ferriani, Rui Alberto
机构：
[1] Univ Sao Paulo, Dept Obstet & Ginecol, Fac Med Ribeirao Preto, BR-14049900 Ribeirao Preto, Brazil
[2] Univ Estadual Campinas, Dept Obstet & Gynecol, Sch Med Campinas, Campinas, Brazil
[3] Univ Sao Paulo, Sch Med Sao Paulo, Dept Obstet & Gynecol, Sao Paulo, Brazil
来源：
FERTILITY AND STERILITY | 2006年 / 86卷 / 03期
关键词：
D O I：
10.1016/j.fertnstert.2006.02.082
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
This study compared the long-term effects of the levonorgestrel-releasing intrauterine device with those of GnRH agonist administration on serum levels of CA-125 in patients with endometriosis. The levonorgestrel-releasing intrauterine device was found to be as efficient as GnRH agonist in reducing CA-125 serum levels.
引用
收藏
页码：742 / 744
页数：3
相关论文
共 15 条
  • [1] Morphological changes and protein secretion induced by progesterone in the endometrium during the luteal phase in preparation for nidation
    Bergeron, C
    [J]. HUMAN REPRODUCTION, 2000, 15 : 119 - 128
  • [2] Fluctuations in CA 125 and CA 15-3 serum concentrations during spontaneous ovulatory cycles
    Bon, GG
    Kenemans, P
    Dekker, JJ
    Hompes, PG
    Verstraeten, RA
    van Kamp, GJ
    Schoemaker, J
    [J]. HUMAN REPRODUCTION, 1999, 14 (02) : 566 - 570
  • [3] Serum CA-125 in Preoperative patients at high risk for endometriosis
    Cheng, YM
    Wang, ST
    Chou, CY
    [J]. OBSTETRICS AND GYNECOLOGY, 2002, 99 (03) : 375 - 380
  • [4] Usefulness and limits of CA-125 in diagnosis of endometriosis without associated ovarian endometriomas
    Kitawaki, J
    Ishihara, H
    Koshiba, H
    Kiyomizu, M
    Teramoto, M
    Kitaoka, Y
    Honjo, H
    [J]. HUMAN REPRODUCTION, 2005, 20 (07) : 1999 - 2003
  • [5] The evaluation of the effectiveness of an intrauterine-administered progestogen (levonorgestrel) in the symptomatic treatment of endometriosis and in the staging of the disease
    Lockhat, FB
    Emembolu, JO
    Konje, JC
    [J]. HUMAN REPRODUCTION, 2004, 19 (01) : 179 - 184
  • [6] MASAHASHI T, 1988, OBSTET GYNECOL, V72, P328
  • [7] Matalliotakis IM, 2004, INT J FERTIL WOMEN M, V49, P75
  • [8] High concentrations of the CA-125, CA 19-9 and CA 15-3 in the peritoneal fluid between patients with and without endometriosis
    Matalliotakis I.M.
    Goumenou A.G.
    Mulayim N.
    Karkavitsas N.
    Koumantakis E.E.
    [J]. Archives of Gynecology and Obstetrics, 2005, 271 (1) : 40 - 45
  • [9] Effect of GnRH analogues on apoptosis and release of interleukin-1β and vascular endothelial growth factor in endometrial cell cultures from patients with endometriosis
    Meresman, GF
    Bilotas, MA
    Lombardi, E
    Tesone, M
    Sueldo, C
    Barañao, RI
    [J]. HUMAN REPRODUCTION, 2003, 18 (09) : 1767 - 1771
  • [10] NILOFF JM, 1984, OBSTET GYNECOL, V64, P703
12